Trends in anal cancer in Australia, 1982-2005

Vaccine

Volumn 29, Issue 12, 2011, Pages 1982-2005

  Jin, Fengyi ^a,b   Stein, Alicia N ^c   Conway, E Lynne ^c   Regan, David G ^a   Law, Matthew ^a   Brotherton, Julia M L ^d   Hocking, Jane ^e   Grulich, Andrew E ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CSL LIMITED   (Australia)

^d VICTORIAN CYTOLOGY SERVICE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Anal cancer; Australia; Incidence; Surveillance; Trend

Indexed keywords

WART VIRUS VACCINE;

ADENOCARCINOMA; ADULT; AGE; AGED; ANUS CANCER; ANUS CARCINOMA; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER INVASION; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PRIORITY JOURNAL; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION; WART VIRUS;

EID: 79951809662     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.015     Document Type: Article

References (37)

1. Frisch M., Glimelius B., van den Brule A.J., Wohlfahrt J., Meijer C.J., Walboomers J.M., et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997, 337:1350-1358.
2. Daling J.R., Madeleine M.M., Johnson L.G., Schwartz S.M., Shera K.A., Wurscher M.A., et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004, 101:270-280.
3. Hoots B.E., Palefsky J.M., Pimenta J.M., Smith J.S. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009, 124:2375-2383.
4. Noffsinger A., Witte D., Fenoglio-Preiser C.M. The relationship of human papillomaviruses to anorectal neoplasia. Cancer 1992, 70:1276-1287.
5. Grulich A.E., Jin F., Conway E.L., Stein A.N., Hocking J. Cancers attributable to human papillomavirus infection. Sex Health 2010, 7:244-252.
6. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007, 356:1915-1927. FUTURE Study II Group.
7. Paavonen J., Jenkins D., Bosch F.X., Naud P., Salmeron J., Wheeler C.M., et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007, 369:2161-2170.
8. Palefsky J. Quadrivalent HPV vaccine efficacy against anal intraepithelial neoplasia in men having sex with men. European Research Organisation on Genital Infection and Neoplasia Congress 2010, The Male Quadrivalent HPV Vaccine Efficacy Trial Team.
9. Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull 2002, 49:194-209.
10. Gillison M.L., Chaturvedi A.K., Lowy D.R. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008, 113:3036-3046.
11. Frisch M., Melbye M. Anal cancer. Cancer epidemiology and prevention 2006, Oxford University Press, New York. 3rd ed. D. Schottenfeld, J.F. Fraumeni (Eds.).
12. Johnson L.G., Madeleine M.M., Newcomer L.M., Schwartz S.M., Daling J.R. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004, 101:281-288.
13. Joseph D.A., Miller J.W., Wu X., Chen V.W., Morris C.R., Goodman M.T., et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008, 113:2892-2900.
14. Robinson D., Coupland V., Moller H. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer 2009, 100:527-531.
15. Brewster D.H., Bhatti L.A. Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer 2006, 95:87-90.
16. Australian Bureau of Statistics Australian historical population statistics, 2008 2008, Australian Bureau of Statistics, Canberra.
17. Frisch M., Melbye M., Moller H. Trends in incidence of anal cancer in Denmark. BMJ 1993, 306:419-422.
18. Goldman S., Glimelius B., Nilsson B., Pahlman L. Incidence of anal epidermoid carcinoma in Sweden 1970-1984. Acta Chir Scand 1989, 155:191-197.
19. Prestage G., Mao L., Fogarty A., Van de Ven P., Kippax S., Crawford J., et al. How has the sexual behaviour of gay men changed since the onset of AIDS: 1986-2003. Aust N Z J Public Health 2005, 29:530-535.
20. Satterwhite C.L., Kamb M.L., Metcalf C., Douglas J.M., Malotte C.K., Paul S., et al. Changes in sexual behavior and STD prevalence among heterosexual STD clinic attendees: 1993-1995 versus 1999-2000. Sex Transm Dis 2007, 34:815-819.
21. Mercer C.H., Fenton K.A., Copas A.J., Wellings K., Erens B., McManus S., et al. Increasing prevalence of male homosexual partnerships and practices in Britain 1990-2000: evidence from national probability surveys. AIDS 2004, 18:1453-1458.
22. Rissel C.E., Richters J., Grulich A.E., de Visser R.O., Smith A.M. Sex in Australia: first experiences of vaginal intercourse and oral sex among a representative sample of adults. Aust N Z J Public Health 2003, 27:131-137.
23. de Visser R.O., Smith A.M., Rissel C.E., Richters J., Grulich A.E. Sex in Australia: heterosexual experience and recent heterosexual encounters among a representative sample of adults. Aust N Z J Public Health 2003, 27:146-154.
24. Daling J.R., Weiss N.S., Hislop T.G., Maden C., Coates R.J., Sherman K.J., et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987, 317:973-977.
25. D'Souza G., Wiley D.J., Li X., Chmiel J.S., Margolick J.B., Cranston R.D., et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008, 48:491-499.
26. Frisch M., Smith E., Grulich A., Johansen C. Cancer in a population-based cohort of men and women in registered homosexual partnerships. Am J Epidemiol 2003, 157:966-972.
27. Cress R.D., Holly E.A. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999. Prev Med 2003, 36:555-560.
28. Ryan D.P., Compton C.C., Mayer R.J. Carcinoma of the anal canal. N Engl J Med 2000, 342:792-800.
29. Goodman M.T., Shvetsov Y.B., McDuffie K., Wilkens L.R., Zhu X., Thompson P.J., et al. Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis 2010, 201:1331-1339.
30. Grulich A.E., van Leeuwen M.T., Falster M.O., Vajdic C.M. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007, 370:59-67.
31. Diamond C., Taylor T.H., Aboumrad T., Bringman D., Anton-Culver H. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005, 32:314-320.
32. Franceschi S., Lise M., Clifford G.M., Rickenbach M., Levi F., Maspoli M., et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV cohort study. Br J Cancer 2010, 103:416-422.
33. Peto J., Gilham C., Fletcher O., Matthews F.E. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004, 364:249-256.
34. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., Borras J., et al. International trends in incidence of cervical cancer. II: squamous-cell carcinoma. Int J Cancer 2000, 86:429-435.
35. Palefsky J.M., Holly E.A., Hogeboom C.J., Berry J.M., Jay N., Darragh T.M. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:415-422.
36. Anderson J.S., Vajdic C., Grulich A.E. Is screening for anal cancer warranted in homosexual men?. Sex Health 2004, 1:137-140.
37. Vajdic C.M., van Leeuwen M.T., Jin F., Prestage G., Medley G., Hillman R.J., et al. Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm Infect 2009, 85:330-335.